» Authors » Miriam Diez-Diez

Miriam Diez-Diez

Explore the profile of Miriam Diez-Diez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 80
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Diez-Diez M, Ramos-Neble B, de la Barrera J, Silla-Castro J, Quintas A, Vazquez E, et al.
Nat Med . 2024 Aug; 30(10):2857-2866. PMID: 39215150
Clonal hematopoiesis, a condition in which acquired somatic mutations in hematopoietic stem cells lead to the outgrowth of a mutant hematopoietic clone, is associated with a higher risk of hematological...
2.
Diez-Diez M, Amoros-Perez M, de la Barrera J, Vazquez E, Quintas A, Pascual-Figal D, et al.
Geroscience . 2022 Jun; 45(2):1231-1236. PMID: 35752705
Clonal hematopoiesis of indeterminate potential (CHIP), defined as the presence of somatic mutations in cancer-related genes in blood cells in the absence of hematological cancer, has recently emerged as an...
3.
4.
Pascual-Figal D, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, Vazquez-Andres D, de la Barrera J, et al.
J Am Coll Cardiol . 2021 Apr; 77(14):1747-1759. PMID: 33832602
Background: Clonal hematopoiesis driven by somatic mutations in hematopoietic cells, frequently called clonal hematopoiesis of indeterminate potential (CHIP), has been associated with adverse cardiovascular outcomes in population-based studies and in...
5.
Carbonell D, Suarez-Gonzalez J, Chicano M, Andres-Zayas C, Diez-Diez M, Rodriguez-Macias G, et al.
Leuk Lymphoma . 2020 Dec; 62(5):1178-1186. PMID: 33372822
Although acute myeloid leukemia (AML) with -ITD is a low-risk entity, its relapse rate remains high. Out of 333 AML patients, 27 were , and were analyzed in greater detail...